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Absence of the proteoglycan 
decorin reduces glucose tolerance 
in overfed male mice
Jessica svärd1,2, Therese H. Røst1,2, Camilla E. N. sommervoll1,2, Christine Haugen1,2, 
Oddrun A. Gudbrandsen3, Anne E. Mellgren3,4, Eyvind Rødahl3,4, Johan Fernø1,2, 
Simon N. Dankel1,2, Jørn V. sagen1,2 & Gunnar Mellgren  1,2
Studies have implicated the extracellular matrix (ECM) of adipose tissue in insulin resistance. 
The proteoglycan decorin, a component of ECM, has been associated with glucose tolerance, but 
possible causal effects on metabolism remain to be explored. We here sought to determine metabolic 
consequences of loss of decorin in mice (DcnKO). DcnKO mice were fed a low-fat (LF) or high-fat 
(HF) diet for 10 weeks and body weight and food intake was recorded. An intraperitoneal glucose 
tolerance test was performed after eight weeks. Blood samples and adipose, liver and muscle tissues 
were collected at sacrifice. Global gene expression was measured in adipose tissue, and expression of 
decorin was also analyzed in human adipose samples. DcnKO mice showed increased feed efficiency 
during overfeeding and impaired glucose tolerance. Adipose leptin mRNA and circulating leptin levels 
were elevated in DcnKO mice, along with a downregulation of genes involved in ECM organization 
and triglyceride biosynthesis, and an upregulation of adipose genes involved in complement and 
coagulation cascades. Consistent with a protective metabolic role for decorin, in obese patients we 
found increased adipose decorin expression after profound fat loss, particularly in the stromal vascular 
fraction. Loss of decorin in mice caused impaired glucose tolerance in association with increased feed 
efficiency and altered gene expression in adipose tissue. Our data provide evidence that decorin is an 
important factor for maintaining glucose tolerance.
Obesity has become more prevalent during the last decades, and it is associated with metabolic disturbances 
which can be related to structural changes in tissues and cross-talk between different organs. During develop-
ment of obesity, gene programs are activated within adipose tissue to support tissue expansion1,2. Adipose tissue 
is a loose connective tissue where adipocytes and adipocyte precursors are embedded in an extracellular matrix 
(ECM) composed of structural proteins (e.g., collagens and elastin) and adhesion proteins (e.g., proteoglycans), 
providing structural support and also regulating intercellular communication3,4. Synthesis and degradation of 
ECM proteins may play an important role in the regulation of adipose tissue size and function during obesity 
progression5, and expression of ECM proteins and ECM remodeling pathway are altered in obesity and type 
2-diabetes6. Several ECM components, including collagen type VI, biglycan and tenascin C, have been implicated 
in metabolic dysregulation in obesity7–13.
The small leucine rich proteoglycan decorin (Dcn) is a component of the ECM in many tissues. It is highly 
expressed in adipose tissue, and more highly expressed in visceral compared to subcutaneous adipose tissue 
depots14,15. Experiments with fractionized adipose tissue show that expression of decorin is highest in the 
non-adipocyte stromal vascular fraction (SVF) that contains, e.g., adipocyte precursors14. Previous studies of 
rodents and humans with obesity and glucose intolerance have suggested increased expression of decorin mRNA 
in whole adipose tissue and secreted decorin protein in plasma14,16. Leptin may be involved in the regulation of 
decorin expression since ob/ob mice, despite a massive increase in body weight, have a reduced expression of 
decorin in epididymal adipose tissue16. Furthermore, decorin polymorphisms were recently found to associate 
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with higher serum glucose in humans17. Decorin may at least partly influence metabolism and adipose tissue 
expansion through its function as a receptor on adipocyte progenitors for the adipokine resistin18, and SNPs 
near the decorin (DCN) gene were found to associate with circulating resistin in Japanese people19. Furthermore, 
decorin interacts with several molecules present in the ECM, including structural proteins such as types VI, XII 
and XIV collagen, fibronectin and elastin20–24, and growth factors such as EGF, TGFβ, TNFα and myostatin25–28. 
These interactions may, in addition to stabilizing the extracellular matrix, also participate in regulating the metab-
olism29 and activity of these growth factors at its receptors. These findings indicate that decorin may play an 
important role in adipose tissue function and in the pathophysiology of obesity.
In the present study, we used the well-established C57BL/6 mouse model for obesity and impaired glucose 
tolerance and type 2 diabetes30, to test a possible causal impact of decorin on body weight, glucose tolerance and 
adipose tissue in high-fat challenged Dcn null (dcnKO) C57BL/6J mice.
Materials and Methods
Animals and diets. The animal experiment was performed in accordance with the Norwegian regulation 
on animal experimentation. The protocol was approved by the Norwegian State Board of Biological Experiments 
with Living Animals (Approval No. 2013–6770). The male mice were kept at the Vivarium, University of Bergen, 
Norway. The Dcn knock-out strain was created by the use of homologous recombination, which was performed 
by genOway, Lyon, France. Removal of exon 8 by mating with Cre-expressing mice resulted in degradation of 
Dcn mRNA. No decorin protein could be detected by western blot in the Dcn KO strain31 and Fig. 1B. The strain 
was back-crossed for 9 generations using C57BL/6J (BomTac) before experiments and is available at The Jackson 
Laboratory Repository with the JAX Stock No. 27672, B6.129S(Cg)-Dcntm1.2Geno/AecmJ (http://jaxmice.jax.org/
query). C57BL/6J (BomTac) (WT) mice or DcnKO on the same background were housed, one per cage, at con-
stant temperature (22 ± 2 °C) and humidity (55 ± 5%), and exposed to a 12 h light–dark cycle with unrestricted 
access to food and tap water.
Eight male WT mice and eight male DcnKO mice were fed a low fat diet (LF) with 3,85 kcal/g, 10 kcal% fat, 
70 kcal% carbohydrates, 20 kcal% protein and 35 kcal% sucrose (Research Diets, New Brunswick, NJ; Cat. No. 
D12450B) and 10 WT mice and 10 DcnKO mice were fed a high fat diet (HF) with 4,73 kcal/g, 45 kcal% fat, 
35 kcal% carbohydrates, 20 kcal% protein and 17 kcal% sucrose (Research Diets, New Brunswick, NJ; Cat. No. 
D12451) for 10 weeks starting at an age of 12 weeks. Diets were packed airtight and stored at 4 °C until used to 
prevent lipid oxidation. Body weights were measured once each week.
Food intake. The weights of food given and remaining in cages were measured once each week and the con-
sumed total amount of food was calculated.
RNA isolation and qPCR analysis. Total RNA was extracted from 10–100 mg of tissue using the RNA/
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Figure 1. Dcn mRNA and protein expression in different metabolic tissues of DcnKO and wild-type (WT) 
C57BL/6J mice. Male mice were fed a low-fat (LF, n = 8) or high-fat (HF, n = 10) diet for 10 weeks, and tissues 
were collected immediately after being euthanized. RNA was purified, cDNA was synthesized and relative gene 
expression was measured by qPCR using Rps13 as a reference gene. iWAT, inguinal white adipose tissue; eWAT, 
epididymal white adipose tissue; BAT, interscapular brown adipose tissue. *p-value < 0.05. (A) Protein levels of 
Dcn in different adipose tissues was determined by western blotting relative to the reference Vinculin (B).
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protocols. The concentration of RNA was determined by spectrophotometry (Nanodrop ND-1000; NanoDrop 
Technologies, Wilmington, DE), and RNA integrity was confirmed by bioanalysis (Agilent 2100 bioanalyzer; 
Agilent Technologies, Inc., Santa Clara, CA).
RNA samples (0.5 μg) were reverse transcribed using the Applied Biosystems™ High-Capacity cDNA Reverse 
Transcription Kit. The cDNA template was synthesized following the protocol that includes 10 uL RNA sam-
ple, 2.0 uL 10X RT Buffer, 0.8 uL dNTP Mix, 2.0 uL10X RT Random Primers, 1.0 uL MultiScribe™ Reverse 
Transcriptase, 1.0 uL RNase Inhibitor, and 3.2 uL nuclease-free H2O. Total volume per reaction was 20.0 uL.
Genes of interest were analyzed by individual real-time SYBR green PCR assays with HPRT or RPS13 used 
as an internal control. The SYBR Green based PCR was carried out on the LightCycler® 480 Real-Time PCR 
System (Roche). The PCR reaction was prepared in a total volume of 10 uL containing 1.5 ul cDNA template, 0.5 
ul of each primer (20 uM), 5 ul of SYBR Green and 2.75 deionized water. A negative control was established by 
replacing cDNA template with deionized water. The expression level of each gene was calculated relative to the 
expression of the reference gene using the 2−ΔΔCt method.
Protein isolation and western blot analysis. Protein was isolated from tissues using the RNA/Protein 
Purificatiion Plus kit (Cat. 48200); Norgen Biotek. Protein samples (10 µg total protein) were separated by elec-
trophoresis in a 10% SDS-polyacrylamide gel (TGX Precast Protein Gels) and subsequently transferred to a 
nitrocellulose membrane (Nitrocellulose Transfer Pack) using the Trans-Blot® Turbo Transfer System (Bio-Rad 
Laboratories, Inc.). All membranes were transferred by the 7 minute pre-set setting and blocked for 1 hour at 
room temperature (RT) in 5% non-fat dry milk in Tris-buffered saline (TBS; 20 mm Tris-HCl, 140 mM NaCl pH 
7.4), containing 0.1% Tween® 20 (0.1% TBS-T). Immunodetection was carried out by incubating the primary 
antibody of interest at 4 °C overnight in either 3% BSA (α-hDecorin (1:2000); AF143 R&D Systems and α-pAKT, 
Ser473, (1:1000); Cell Signaling Tech.®) or 5% BSA (α-Vinculin (1:2000); Abcam and α-AKT (1:1000); Cell 
Signaling Tech.®). HRP-conjugated goat-anti-rabbit IgG or goat-anti-rabbit IgG was used as the respective sec-
ondary antibodies (Cell Signaling Tech.®). Between all steps throughout the procedure, membranes were washed 
extensively in 0.1% TBS-T at RT. Anti-Vinculin was verified by comparing signals to stain-free total protein 
measurements and subsequently used as loading control in all immunoblots. Chemiluminescence of secondary 
antibody-HRP conjugates was elicited using SuperSignal West Femto Maximum Sensitivity Substrate (Thermo 
Scientific) and imaged with Gel DocTM XR+ (Bio-Rad Laboratories, Inc.) and quantified using Image Lab 6.0 
software (Bio-Rad Laboratories, Inc.).
Blood and tissue samples. Animals were fasted for 6 hours, anesthetized with 2% isoflurane 
(Schering-Plough, Kent, UK) and blood was collected by heart puncture before the mouse was euthanized. The 
blood was centrifuged, EDTA-plasma separated and stored at −80 °C prior to further analysis. Liver, epididymal 
white adipose tissue (eWAT), inguinal WAT (iWAT), skeletal muscle (gastrocnemius) and BAT were collected and 
immediately frozen in liquid nitrogen and stored at −80 °C until further analysis.
Fasting EDTA-plasma samples at study endpoint were analyzed for Total Cholesterol, HDL Cholesterol, LDL 
Cholesterol, Triglycerides, Non-esterified fatty acids (NEFA) using the Cobas C111 System (Roche Diagnostics 
GmbH, Mannheim, Germany). Standard kits were used for all except for NEFAs that were analyzed using the 
NEFA FS kit (DiaSys, Diagnostic Systems GmbH, Germany). Lipids were measured by enzymatic colorimetric 
assays with specific reagents from Roche Diagnostics for total cholesterol (CHOL2, Cat. No. 04718917190), tri-
glycerides (TRIGL, Cat. No. 04657594190), HDL cholesterol (HDL, Cat. No. 05401488190), and LDL cholesterol 
(LDL C, Cat. No. 04657578190). Insulin (Cat. No. 90080) and Leptin (Cat. No. 90030) were measured by ELISA 
from (Crystal Chem, Downers Grove, IL, USA).
Glucose tolerance test (GTT). Intraperitoneal (IP) GTTs were performed at 20 weeks of age (after 8 weeks 
on HF or low fat diet (LF)). For GTTs animals were fasted for 5 hours, and glucose (2 g/kg body weight) was 
injected IP. Blood glucose was measured from the saphenous vein using a glucometer (Contour, Bayer) at 0, 15, 
30, 60, 120 and 180 min after glucose injection in un-anesthetized mice.
Histology and adipocyte size measurement. Formalin fixed, paraffin embedded eWAT was sectioned 
(5 μm) on a Leica RM2255 microtome. Hematoxylin and eosin (H&E) staining was performed on three to five 
sections per animal. Images were captured under bright-field illumination using a Nikon microscope (E800; 
Tokyo, Japan) with a Plan Apo ×10 (NA 0.75) objective.
Microarray analysis. Global gene expression analysis was performed in iWAT from 8 WT and 8 DcnKO 
mice on LFD or HFD using Illumina Mouse Microarray at The Genomics Core Facility (GCF) at the University 
of Bergen.
Patients. A description of human patients can be found in32. The study of human subjects was approved by 
the Regional committee for medical and health research ethics, western Norway (REC West). Each subject gave 
written informed consent, and the study was performed in accordance with the declaration of Helsinki.
Statistical analyses. Statistical analyses were conducted using SPSS Statistics 22. All values are represented 
as the mean ± sem. Significance between two groups was assessed using 2-way ANOVAs or two-tailed unpaired 
or paired Student’s t-test. P < 0.05 was considered significant. Number of animals and persons used for all meas-
ures are provided in figure legends.
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Results
Diet-induced increase in Dcn mRNA expression in different adipose tissues. Studies have shown 
that rodents and humans with obesity and glucose intolerance have increased expression of decorin in adipose 
tissue14,16. In this study we further examined diet-dependent decorin expression in different adipose tissue depots 
and other metabolic tissues of mice fed a control low-fat diet. As expected we found that high-fat (HF) feeding 
increased Dcn mRNA in epididymal white adipose tissue (eWAT) (Fig. 1A). We also found increased expression 
of Dcn in inguinal white adipose tissue (iWAT), brown adipose tissue (BAT), and skeletal muscle, whereas there 
was no difference in the hepatic gene expression (Fig. 1A). To confirm loss of Dcn protein in tissues of DcnKO 
mice, we purified protein from iWAT and eWAT of WT and DcnKO mice fed a LF or a HF diet. We could not 
detect expression of Dcn in inguinal white adipose tissue (iWAT) or epididymal white adipose tissue (eWAT) of 
DcnKO mice. The reference gene, Vinculin, was detected as a technical control (Fig. 1B).
Increased weight gain and feed efficiency in DcnKO. To test the role of decorin in body weight reg-
ulation, we fed WT and DcnKO mice a HF or LF diet. At study start the body weights were not different in the 
LF groups 25.2 ± 0.6 g (WT) and 26.1 ± 0.7 g (DcnKO), or in the HF groups 27.5 ± 0.3 g (WT) and 26.7 ± 0.7 g 
(DcnKO) respectively. Both WT and KO mice gained considerably more weight on HF compared to LF diet 
(Fig. 2A). During the first four weeks, the WT and DcnKO mice fed HF gained similar amounts of weight. In con-
trast, the DcnKO mice gained surprisingly more weight, with a significant difference in accumulated weight gain 
seen at 8 weeks (Fig. 2A). However, after the full 10 weeks on HF, weight gain did not differ significantly between 
the two genotypes (Fig. 2A), which was also the case on LF (Fig. 2A). Moreover, we did not find an interaction 
between diet and genotype calculated by a 2-way ANOVA. However, while food intake was not different between 
the genotypes on either HF or LF diet (Fig. 2B), the DcnKO mice showed significantly higher feed efficiency 
(amount of weight gained relative to food intake) compared to WT on the HF diet (week 10, Fig. 2C). Feed effi-
ciency was not significantly different between the two genotypes after 10 weeks of LF feeding (Fig. 2C).
Higher concentration of leptin in DcnKO mice. The difference in body weight and feed efficiency 
between WT and KO mice upon HF feeding prompted us to measure circulating leptin, which reflects fat mass33. 
As expected, HF feeding increased the levels of leptin both in plasma and in iWAT and eWAT compared to 
LF (Fig. 2D,E). Interestingly, plasma leptin as well as mRNA levels of leptin in eWAT and iWAT were higher 
in DcnKO than in WT fed a LF diet, but the higher level of leptin upon HF feeding in both genotypes gave no 
significant difference during HF (Fig. 2D,E). Moreover, we found no significant differences in the expression of 
adiponectin or resistin mRNA in iWAT or eWAT between WT and DcnKO animals (Fig. 2F,G).
Leptin has previously been shown to associate more closely with adipocyte hypertrophy than hyperplasia34, 
and we therefore further assessed adipocyte size in eWAT of the DcnKO and WT mice. In agreement with the 
higher leptin upon HF compared to LF feeding, adipocytes in eWAT were larger in mice after the HF diet for both 
genotypes (Fig. 2H,I). However, we observed no significant differences between the genotypes after either diet 
(Fig. 2H,I), suggesting that adipocytes in the DcnKO mice were unable to expand in size beyond the diet effect. 
Because leptin has a proadipogenic (i.e. hyperplasic) effect on preadipocytes35, the higher leptin upon LF feeding 
in the DcnKO mice may reflect an effect of decorin on leptin-mediated adipogenesis/hyperplasia, rather than 
primarily on hypertrophy.
Reduced glucose tolerance in DcnKO mice on HF. Changes in the extracellular matrix have been 
demonstrated to play a causal role in fat mass regulation as well as in whole-body glucose tolerance8. Accordingly, 
we wanted to find out whether DcnKO mice would show altered glucose metabolism in response to HF feeding. 
After 8 weeks on HF, the fasting glucose level was significantly higher in DcnKO mice (10.6 ± 0.6 mmol/L) com-
pared to WT mice (8.3 ± 0.4 mmol/L) (Fig. 2J). Further, we performed an intraperitoneal glucose tolerance test 
(GTT), revealing higher glucose levels at 60 and 120 min in DcnKO mice given HF feeding compared to WT 
mice on the same diet. This translated into a significantly higher area under the curve (AUC) glucose for DcnKO 
compared to WT mice (Fig. 2K). No difference in glucose tolerance was found between WT and DcnKO mice on 
LF. No significant differences in plasma insulin concentrations were observed between the groups, even though 
it was higher in DcnKO mice in both the LF and HF groups (Table 1), suggesting that DcnKO mice had some 
increase in insulin resistance compared to WT animals. The difference in glucose levels could not be explained 
by differences in the expression levels of different glucose transporters or any apparent differences in insulin sig-
naling (Fig. S1). However, we found a small but significantly decreased expression of Ucp1 in BAT from DcnKO 
mice fed HF (Fig. S2).
Effect of genotype and diet on lipids. To gain further insight into the metabolic consequences of loss of 
decorin circulating lipids were analyzed (Table 1). Plasma concentrations of total cholesterol, HDL cholesterol, 
LDL cholesterol, Non-Esterified Fatty Acids (NEFA) and total bile acids were not different between the WT and 
DcnKO groups on either diet. However, the triglyceride concentration was significantly higher in the DcnKO 
group on the LF diet, and a similar tendency was seen for the HF diet.
Differentially expressed genes in adipose tissue. To evaluate possible mechanisms involved in the 
lower glucose tolerance in the DcnKO mice, we measured global gene expression in iWAT from the WT and 
DcnKO mice after 10 weeks on either diet. For the LF diet, we found 10 transcripts with higher expression and 
10 transcripts with lower expression in DcnKO compared to WT, within a false discovery rate (FDR) cut-off of 0 
(Table 2). With the same cutoff on the HF diet, we found 22 transcripts with higher expression and 20 transcripts 
with lower expression in DcnKO compared to WT. Decorin was confirmed to be the most downregulated gene 
after both diets, and Prtn3 was one of the most downregulated and Hal the most upregulated gene in DcnKO com-
pared to WT mice on both diets (Tables 2 and 3). Prtn3 (proteinase 3) is a serine protease that degrades elastin, 
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Figure 2. Changes in metabolic phenotype in Dcn knock-out (DcnKO) relative to wild-type (WT) C57BL/6J 
mice. Twelve week old male mice were subjected to a low-fat (LF) or high-fat (HF) diet for 10 weeks. Body 
weight (A) and food intake (B) were measured every week, and feed efficiency (grams of weight gain per unit 
of caloric intake) was calculated (C). Lep mRNA in adipose tissue was measured by qPCR calculated relative to 
the reference gene Rps13 (D), and circulating levels of leptin were measured in plasma by ELISA (E). Adipoq 
and Retn mRNA in adipose tissue was measured by qPCR calculated relative to the reference gene Rps13 (F,G). 
Mean adipocyte size in inguinal white adipose tissue (iWAT) was calculated by measuring 50–100 adipocytes 
on 3–5 slides per animal (H). Representative images of the hematoxylin and eosin (H&E) stained adipose tissue 
are shown (I). A glucose tolerance test (GTT) was performed after 8 weeks on the diets, with intraperitoneal 
glucose injection (2 g/kg body weight) after a 5 hour fast (J), and area under the curve (AUC) was measured 
based on the repeated measurements of blood glucose (K). *p-value < 0.05, **p-value < 0.01.
LF HF
Wt DcnKO Wt DcnKO
Cholesterol (mmol/L) 2,14 ± 0,07 2,05 ± 0,14 2,87 ± 0,25 2,50 ± 0,07
HDL (mmol/L) 2,01 ± 0,04 1,94 ± 0,13 2,76 ± 0,27 2,45 ± 0,10
LDL (mmol/L) 0,41 ± 0,06 0,30 ± 0,02 0,39 ± 0,07 0,22 ± 0,04
TG (mmol/L) 0,45 ± 0,03 0,58 ± 0,04*# 0,58 ± 0,03 0,69 ± 0,04
NEFA (mmol/L) 0,24 ± 0,03 0,28 ± 0,02 0,23 ± 0,03 0,24 ± 0,06
Insulin (ng/ml) 0,40 ± 0,08 0,64 ± 0,14 0,62 ± 0,14 0,87 ± 0,24
Bile acids (mmol/L) 6,2 ± 2,3 4,3 ± 1,5 2,6 ± 1,1 3,8 ± 0,4
Table 1. Biochemical parameters in plasma of wt and DcnKO mice. LF, low-fat; HF, high-fat; HDL, high-
density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides; NEFA, Non-esterified fatty acids. 
#Significance level for comparison of Wt mice with DcnKO mice.
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fibronectin, laminin, vitronectin, and collagen types I, III, and IV36, whereas Hal (Histidine ammonia-lyase) 
catalyzes breakdown of histidine, an amino acid shown to improve insulin resistance in obese women37.
To more systematically assess biological functions represented by the top regulated genes, we performed path-
way enrichment analysis based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Consistent 
with the role of decorin in extracellular matrix, transcripts induced in DcnKO on LF were enriched in the path-
ways Extracellular matrix organization, Collagen biosynthesis and modifying enzymes, and Collagen degradation 
(Fig. 3A), and transcripts downregulated in DcnKO mice were enriched in the pathways Striated muscle contrac-
tion and Muscle contraction (Fig. 3A). On the HF diet, upregulated transcripts in DcnKO were enriched in the 
pathways, e.g. complement and coagulation cascades and platelet degranulation (Fig. 3B), while downregulated 
transcripts were enriched in the pathways, e.g., triglyceride biosynthesis and metabolism (Fig. 3B), supporting a 
role for decorin in adipose tissue lipid metabolism and inflammation.
Adipose DCN expression increases upon profound fat loss in humans. Finally, we analyzed DCN 
mRNA expression by qPCR in subcutaneous adipose tissue of human subjects before and one year after bar-
iatric surgery (biliopancreatic diversion with duodenal switch (n = 13)32. A significantly increased expression 
of decorin mRNA was observed one year after surgery (Fig. 4A). The results were confirmed in another set of 
patients with another surgical procedure (gastric sleeve), (n = 6) (Fig. 4B). Subcutaneous adipose tissue samples 
from these patients were fractionized into an adipocyte fraction and a stromal vascular fraction (SVF). Decorin 
was predominantly expressed in the SVF and the significant increase in expression one year after surgery is only 
seen in the SVF although the same tendency seems to be present in the adipocyte fraction (Fig. 4B).
Discussion
We here studied the impact of loss of decorin on obesity-related phenotypes, hypothesizing that decorin plays 
an important role in the regulation of body weight, glucose tolerance and adipose tissue function. Our primary 
finding is that loss of decorin in mice impaired glucose tolerance and increased feed efficiency upon overfeeding, 
indicating that decorin plays a causal role in regulating glucose metabolism. We further mapped the global gene 
expression in adipose tissue associated with this phenotype, which pointed to reduced extracellular matrix organ-
ization and triglyceride biosynthesis in the DcnKO mice exposed to HF diet, as well as increased complement 
and coagulation cascades. Our findings in patients showing increased decorin expression one year after bariatric 
surgery support the observation in the mice.
Insulin resistance associates with adipocyte hypertrophy in humans38. Interestingly, despite the impaired glu-
cose tolerance and tendency of increased weight gain in the DcnKO mice, we found no evidence of increased 
adipocyte size. This suggests that loss of decorin negatively affected glucose homeostasis independently of adi-
pocyte hypertrophy. Such a dissociation of insulin resistance and adipocyte hypertrophy is consistent with that 
seen in collagen VI knockout mice, which show a marked hypertrophy of individual adipocytes concomitant with 
improved glucose tolerance8.
Our genome-wide gene expression data indicate that decorin exerts positive metabolic effects by different 
mechanisms. Firstly, several ECM-related genes were differentially regulated in adipose tissue of the DcnKO 
mice, consistent with decorin serving as a component of the ECM in various tissues, including adipose tissue 
where it is highly expressed particularly in the visceral depot and in the stromal-vascular fraction14,15. Obesity 
Probe-ID Gene symbol Full Gene Name Fold Change
ILMN_2747959 Dcn Decorin −74.85
ILMN_2596346 Dcn Decorin −6.10
ILMN_2666864 Atp2a1 ATPase Sarcoplasmic/Endoplasmic Reticulum Ca2+ Transporting 1 −6.44
ILMN_2758029 Prtn3 Proteinase 3 −2.82
ILMN_2481133 Tnni2 Troponin I2, Fast Skeletal Type −5.35
ILMN_1218223 Pvalb Parvalbumin −4.49
ILMN_2977331 Mylpf Myosin Light Chain, Phosphorylatable, Fast Skeletal Muscle −3.92
ILMN_2882658 Tnnc2 Troponin C2, Fast Skeletal Type −4.08
ILMN_2482209 Tpm2 Tropomyosin 2 (Beta) −3.33
ILMN_2469018 Tnnt3 Troponin T3, Fast Skeletal Type −3.00
ILMN_2875730 Mup1 Major urinary protein 1 2.38
ILMN_1213817 Mup3 Major urinary protein 3 3.55
ILMN_2443330 Ttr Transthyretin 3.39
ILMN_2623393 Apoa1 Apolipoprotein A1 2.62
ILMN_2788223 Kng1 Kininogen 1 1.96
ILMN_2659680 Serpina1b Serpin Family A Member 1 2.38
ILMN_1247156 Apoa2 Apolipoprotein A2 4.01
ILMN_2614752 Elovl6 ELOVL Fatty Acid Elongase 6 2.38
ILMN_1225730 Fdps Farnesyl Diphosphate Synthase 1.82
ILMN_2984332 Hal Histidine Ammonia-Lyase 3.31
Table 2. Differentially expressed genes in adipose tissue of low fat fed mice.
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is characterized by extensive reorganization of the extracellular matrix in adipose tissue39, and factors related to 
adipose ECM function have been implicated in obesity-related pathogenesis40 particularly linked to excess colla-
gen fibril formation (fibrosis)8,41. Increased ECM deposition and rigidity in adipose tissue is thought to prevent 
adipose tissue expansion, while also increasing the risk of glucose intolerance during overfeeding due to ectopic 
lipid accumulation. Previous reports have shown increased expression of decorin along with several other ECM 
components in obesity6,14,16, and we also found increased decorin expression in both adipose tissue and muscle 
after overfeeding. However, our causal mouse data and prospective human data indicate that decorin does not 
promote adipose fibrosis and insulin resistance. To the contrary, the reduced glucose tolerance in the DcnKO 
mice is consistent with previous observations that decorin inhibits TGFβ and connective tissue growth factor, 
two established pro-fibrotic factors25,42.
Further, in the knockout compared to wild-type mice we found up-regulation of adipose genes involved in 
complement and coagulation cascades, platelet degranulation and response to elevated platelet cytosolic Ca2+. 
Thrombin-induced increases in cytosolic Ca2+ promote platelet reactivity, a response that is augmented in insu-
lin resistant cells because insulin signaling normally counteracts these pro-coagulation effects of thrombin43,44. 
Probe-ID Gene symbol Full Gene Name Fold Change
ILMN_2747959 Dcn Decorin −168.9
ILMN_2596346 Dcn Decorin −7.61
ILMN_2758029 Prtn3 Proteinase 3 −2.57
ILMN_2661366 Tmem45b Transmembrane Protein 45B −2.18
ILMN_3105563 Dmkn Dermokine −1.31
ILMN_1229763 Dmkn Dermokine −1.34
ILMN_1232524 Hist1h4i Histone Cluster 1 H4 Family Member I −1.68
ILMN_3125966 Kcnj15 Potassium Voltage-Gated Channel Subfamily J Member 15 −1.61
ILMN_2798129 C6 Complement C6 −1.67
ILMN_2710905 S100a8 S100 Calcium Binding Protein A8 −1.60
ILMN_2868152 Krtdap Keratinocyte Differentiation Associated Protein −1.30
ILMN_1216720 C6 Complement C6 −1.55
ILMN_1256775 Thrsp Thyroid Hormone Responsive −1.50
ILMN_1220275 Nrg4 Neuregulin 4 −1.48
ILMN_2863532 Lipf Lipase F, Gastric Type −1.43
ILMN_2948296 Wfdc12 WAP Four-Disulfide Core Domain 12 −1.41
ILMN_2870696 Hfe Hemochromatosis −1.45
ILMN_1218981 Aldh1a7 Aldehyde Dehydrogenase 1 Family Member A1 −1.39
ILMN_1244513 Gbp3 Guanylate Binding Protein 3 −1.42
ILMN_2671165 Krt23 Keratin 23 −1.03
ILMN_2486906 Wisp2 WNT1 Inducible Signaling Pathway Protein 2 1.37
ILMN_3143404 Mup2 Major urinary protein 2 2.35
ILMN_1213817 Mup3 Major urinary protein 3 2.69
ILMN_3065459 Mup2 Major urinary protein 2 3.47
ILMN_2873822 Aebp1 AE Binding Protein 1 1.45
ILMN_2635229 Thbs2 Thrombospondin 2 1.59
ILMN_2875730 Mup1 Major urinary protein 1 2.95
ILMN_2659680 Serpina1b Serpin Family A Member 1 1.94
ILMN_1215859 Serpina1b Serpin Family A Member 1 1.96
ILMN_2953807 Mup6 Major urinary protein 6 2.72
ILMN_1225570 Serpina1d Serpin Family A Member 1 1.99
ILMN_2443330 Ttr Transthyretin 3.03
ILMN_1247156 Apoa2 Apolipoprotein A2 2.83
ILMN_1213954 Sgk1 Serum/Glucocorticoid Regulated Kinase 1 1.48
ILMN_2904137 Ambp Alpha-1-Microglobulin/Bikunin Precursor 2.09
ILMN_2623393 Apoa1 Apolipoprotein A1 2.38
ILMN_2749037 Chchd10 Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 10 1.92
ILMN_2753809 Mmp3 Matrix Metallopeptidase 3 1.37
ILMN_2993745 Ahsg Alpha 2-HS Glycoprotein 1.91
ILMN_3158499 Mdk Midkine 1.48
ILMN_2788223 Kng1 Kininogen 1 1.88
ILMN_2984332 Hal Histidine Ammonia-Lyase 5.25
Table 3. Differentially expressed genes in adipose tissue of high fat fed mice.
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Reducing thrombin action was found to directly improve insulin sensitivity in leptin resistant obese mice, sug-
gesting a causal role for prothrombrotic processes in obesity-related insulin resistance45. Thus, an effect of decorin 
knockout on pro-coagulation cascades may have contributed to the increased diet-induced insulin resistance in 
these mice.
An isoform of decorin has been described as a receptor for the adipose-expressed factor resistin18 named for 
its ability to promote insulin resistance in animal models46. The resistin receptor is formed after cleavage of a 
glycanation site from full-length decorin, and was found to specifically present on the surface of adipose stromal 
cells18. It could be expected that loss of this decorin-derived resistin receptor improves glucose tolerance, but 
we rather found reduced glucose tolerance in the DcnKO mice. In humans, resistin is primarily expressed in 
peripheral-blood mononuclear cells (PMBCs), which along with vascular cells show pro-inflammatory responses 
to resistin47. However, the importance of adipose resistin as a causal factor in insulin resistance remains unclear47.
In our search for specific genes that might have mediated effects of decorin knockout on glucose tolerance 
via adipose tissue, we performed global gene expression profiling and identified two particularly regulated 
genes, Prtn3 (downregulated in knockout mice) (Fig. 5A) and Hal (upregulated in knockout mice) (Fig. 5B). 
Prtn3 encodes Proteinase 3 which degrades ECM components including elastin, fibronectin and several colla-
gen subtypes48. Prtn3 is highly expressed in polymorphonuclear leukocytes such as neutrophils, and plays an 
important role in antimicrobial defense mechanisms. Prtn3 also plays a role in noninfectious inflammation49 and 
elastin-derived peptides accumulate with aging and directly promote insulin resistance50. Of note, a dense mesh 
of elastin fibers forms in visceral adipose tissue during development of obesity, while in subcutaneous adipose 
tissue the elastin fibers occur more linearly and colocalize with macrophages51. However, the downregulation 
of Prtn3 does not readily explain the reduced glucose tolerance in the DcnKO mice, based on the proposed 
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Figure 3. Enriched KEGG pathways for differentially expressed genes in iWAT comparing DcnKO and WT 
C57BL/6J mice. Total RNA was purified from adipose tissue and subjected to microarray analysis. Genes with a 
false discovery rate (FDR) below 20% were analyzed in the Kyoto Encyclopedia of Genes and Genomes (KEGG) 
gene ontology database, and data are presented as log fold enrichment for each significantly enriched category 
(p < 0.05) for up- and down-regulated genes in DcnKO vs. WT, respectively. iWAT, inguinal white adipose 
tissue; LF, low-fat diet; HF, high-fat diet; DcnKO, decorin knock-out mice; WT, wild-type mice.
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stimulatory roles of Prtn3 in inflammation and insulin resistance. More likely, the decreased glucose tolerance 
involved the most upregulated gene, Hal, which encodes a histidase that degrades the amino acid histidine. 
Histidine supplementation has been found to reduce oxidative stress, inflammation and fat mass and to improve 
glucose metabolism in mice, humans and pre-adipocyte cultures37,52–54. Thus, increased Hal expression in the 
DcnKO mice may have contributed to the insulin resistant phenotype by increasing the degradation of histidine.
Decorin is expressed in several tissues and cell types, therefore we cannot say with certainty which tissues were 
primarily responsible for the metabolic phenotype of the knockout mice. We found that decorin mRNA expres-
sion increased upon overfeeding in white and brown adipose tissues as well as in skeletal muscle. The decorin 
expression was relatively low in liver where overfeeding did not notably affect decorin levels. Interestingly, we 
found that Uncoupling protein 1 (Ucp1) mRNA was downregulated in brown adipose tissue (BAT) of dcnKO 





























Figure 4. Adipose expression of DCN mRNA before and after bariatric surgery. Subcutaneous adipose tissue 
was collected from morbidly obese patients before and one year after bariatric surgery (gastric sleeve). RNA 
was purified, cDNA was synthesized and DCN mRNA was measured by qPCR and calculated relative to the 
reference gene HPRT, in whole tissue (A, n = 16) as well as in pairs of isolated adipocytes (n = 6) and stromal-








































































































Figure 5. Tissue expression of the two most differentially expressed genes between DcnKO and WT C57BL/6J 
mice. Global gene expression was measured in iWAT by Illumina microarrays, revealing Prtn3 and Hal as the 
most down- and up-regulated genes, respectively, comparing dcnKO and WT mice. mRNA expression levels 
of Prtn3 (A) and Hal (B) in different metabolic tissues were measured by qPCR and calculated relative to 
the reference gene Rps13. iWAT, inguinal white adipose tissue; eWAT, epididymal white adipose tissue; BAT, 
interscapular brown adipose tissue. *p-value < 0.05; **p-value < 0.01; *p-value < 0.001.
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mice (Fig. S2). No differences in mRNA expression of Pgc1a or Prdm1 were found (Fig. S2). To know the effect 
of decorin loss specifically in adipose tissue, we would need conditional knockout models targeting the most 
relevant stromal vascular cell types. This was beyond the scope of the present study.
In conclusion, we found that decorin plays a causal role in protecting against diet-induced hyperglycemia. 
Previous reports have showed elevated decorin gene expression coupled with increased circulating insulin levels 
and insulin resistance in rodents and humans14,16. In contrast we found that fasting blood glucose was increased 
in absence of Dcn in mice fed HF diet in addition to higher glucose levels throughout the GTT. Moreover, the 
upregulation of decorin in adipose tissue following profound fat loss in humans after bariatric surgery, which has 
a substantial effect on improving glucose homeostasis, further supports a role for decorin in maintaining glucose 
tolerance. Loss of decorin associated with adipose genes involved in complement and coagulation cascades, as 
well as elevated adipose expression of Hal which has been implicated in inflammation and glucose intolerance 
through degradation of histidine. Taken together, our data show that loss of decorin causes glucose intolerance 
upon overfeeding, at least in part via changes in adipose tissue function.
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